Summary of Product Characteristics
last updated on the eMC:
20/09/2006
|
SPC
|
Betadine Dry Powder Spray
|
Go to top of the page | Betadine Dry Powder Spray.
| |
Go to top of the page | Povidone Iodine 2.5% w/w.
| |
Go to top of the page | Pressurised aerosol spray.
| |
Go to top of the pageGo to top of the page | Antiseptic for the treatment and prevention of infection in wounds including ulcers, burns, cuts and other minor injuries.
| |
Go to top of the page | For topical use only. Adults and children aged 2 years and over: Shake the can well before use. Spray the required area from a distance of 15-25cm (6-10 inches) until a dusting of powder is deposited. If necessary, the treated area may be covered with a dressing.
| |
Go to top of the page | Hypersensitivity to iodine. Betadine Dry Powder Spray should not be used in serous cavities. Do not use this product regularly if the patient suffers from thyroid disorders or is receiving concurrent lithium therapy. Do not use on children under two years of age.
| |
Go to top of the page | Avoid inhaling or spraying into the eyes. Avoid use on patients with renal impairment. Should evidence of local irritation or sensitivity occur, use of the product should cease. If no improvement occurs, a doctor should be consulted.
| |
Go to top of the page | Use with concurrent lithium therapy has been shown to exhibit additive hypothyroidic effects.
| |
Go to top of the page | Use in pregnancy or lactation should be limited. Although no adverse effects are anticipated from such limited usage, caution is recommended and therapeutic benefit must be balanced against the possible effects of the absorption of iodine on foetal thyroid function and development.
| |
Go to top of the pageGo to top of the page | Iodine is absorbed through burns and broken skin and to a lesser extent through intact skin. Following prolonged application of Betadine Dry Powder Spray to severe burns or large areas of denuded skin, systemic effects such as metabolic acidosis, parametrical renal impairment and thyroid dysfunction may occur.
| |
Go to top of the page | Excess iodine can produce goitre and hypothyroidism or hyperthyroidism. Systemic absorption of iodine after repeated application of povidone iodine to large areas of wounds or burns may lead to a number of adverse effects: metallic taste in mouth, increased salivation, burning or pain in the throat or mouth, irritation and swelling of the eyes, pulmonary oedema, skin reactions, gastrointestinal upset and diarrhoea, metabolic acidosis, hypernatraemia and renal impairment. Treatment: In the case of deliberate or accidental ingestion of large quantities of Betadine, symptomatic and supportive treatment should be provided with special attention to electrolyte balance and renal and thyroid function.
| |
Go to top of the pageGo to top of the page | Povidone iodine is a complex of iodine which retains the broad-spectrum germicidal activity of the elemental iodine without its disadvantages. The germicidal activity is maintained in the presence of blood, pus, serum and necrotic tissue.
| |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | Isopropyl myristate; n-pentane; butane 40; soya lecithin.
| |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | Aerosol cans containing 100ml of product.
| |
Go to top of the pageGo to top of the page | Medlock Medical Limited, Tubiton House, Medlock Street, Oldham, OL1 3HS.
| |
Go to top of the pageGo to top of the pageGo to top of the page
More information about this product
Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1953/SPC/